PRKAA1 and mitochondrial disease: Our results demonstrate that AMP-independent allosteric activation of AMPK ameliorates both the energy depletion and oxidative stress arising from mitochondrial dysfunction and provide support for these compounds as attractive candidates for treating mitochondrial disease.